A significant hurdle for the Adeno-associated Virus Vector-based Gene Therapy Market is the issue of pre-existing immunity. AAV is a common, non-pathogenic virus that many people are exposed to naturally. As a result, a large percentage of the population has pre-existing neutralizing antibodies (NAbs) against specific AAV serotypes. When an AAV-based gene therapy is administered to a patient...

The global Cell and Gene Therapy Market is poised for remarkable expansion over the next decade, catalyzed by unprecedented advances in regenerative medicine, growing prevalence of chronic and genetic diseases, and sweeping regulatory support worldwide. In 2025, the market is valued at USD 41.3 billion, with forecasts projecting robust growth to USD 143.2 billion by...

“According to a new report published by Introspective Market Research, Biologics Market by Product Type, Application, and Manufacturing, The Global Biologics Market Size Was Valued at USD 509.3 Billion in 2023 and is Projected to Reach USD 1230.70 Billion by 2032, Growing at a CAGR of 10.3%.” Biologics, short for biological products, represent a transformative class of medicines...

Global Cancer Gene Therapy Market reached US$ 4.7 billion in 2024 and is expected to reach US$ 13.2 billion by 2031 growing at a CAGR of 20% during the forecast period 2024-2031. The Cancer Gene Therapy Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable...

Overview Cell and Gene Therapies are revolutionary approaches in treating diseases at their roots. These therapies work by either modifying genes (gene therapy) or manipulating cells (cell therapy), often combining both methods—for instance, gene‐modified cell therapies like CAR‑T, where a patient’s T cells are genetically engineered to target cancer cells. The market includes...

The global Cell and Gene Therapy Market is poised for remarkable expansion over the next decade, catalyzed by unprecedented advances in regenerative medicine, growing prevalence of chronic and genetic diseases, and sweeping regulatory support worldwide. In 2025, the market is valued at USD 41.3 billion, with forecasts projecting robust growth to USD 143.2 billion by...

“According to a new report published by Introspective Market Research, CRISPR and Cas Gene Market by Product Type, Application, and End User, The Global CRISPR and Cas Gene Market Size Was Valued at USD 1.43 Billion in 2023 and is Projected to Reach USD 11.39 Billion by 2032, Growing at a CAGR of 30% from 2024–2032.” The CRISPR and Cas Gene Market represents a transformative...

Executive Summary Europe Gene Therapy Market : Data Bridge Market Research analyzes that the Europe gene therapy market is expected to reach USD  7,422.28 million by 2030, at a CAGR of 17.6% during the forecast period.  The market report also provides the drivers and restraints for the Europe Gene Therapy Market that are obtained with the help of SWOT analysis, and also...

Executive Summary Gene Therapy Market: Share, Size & Strategic Insights The global gene therapy market size was valued at USD 10.26 billion in 2024 and is expected to reach USD 39.38 billion by 2032, at a CAGR of 18.30% during the forecast period The comprehensive Gene Therapy Market report is an insightful and actionable market report which is always in...

The Gene Therapy Market insights on patient accessibility, affordability, and healthcare infrastructure challenges worldwide highlight barriers that influence adoption of advanced gene-based therapies. High therapy costs, limited healthcare facilities, and unequal access across regions restrict patient reach. Companies, regulators, and healthcare providers are exploring solutions to enhance...